Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers
B. D. Kirkpatrick, Robin McKenzie, J. Patrick O'Neill, Catherine J. Larsson, A. Louis Bourgeois, Janet Shimko, Matthew Bentley, Jill Makin, Steve Chatfield, Zoë Hindle, Christine Fidler, Brad E. Robinson, Cassandra H. Ventrone, Nivedita Bansal, Colleen M. Carpenter, Deborah Kutzko, Sandra Hamlet, Casey Lapointe, David N. Taylor
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers'. Together they form a unique fingerprint.